Evidence for NDV-induced tumor antigen-specific CD8+ T cell response comes from studies involving bilateral flank syngeneic tumor models, whereby lentogenic NDV LaSota strain is administered to a single flank tumor [49,51,53,54,60]. The gene discussed is CD8A; the disease is neoplasm.